Skip to main content
. 2019 Dec 17;2019:6490820. doi: 10.1155/2019/6490820

Figure 4.

Figure 4

E2 (a) and P (b) concentrations and the ratio of P/E2 (c) in plasma following 90-day oral exposure to CdCl2 or 17β-estradiol (positive control), at the 90-day and 180-day postexposure periods. p ≤ 0.05 (a—vs. pure control group, b—vs. oil control, and c—vs. positive control).